Inhalable ciprofloxacin/polymyxin B dry powders in respiratory infection therapy
The current study focused on the formulation, physicochemical characterization, and antibacterial susceptibility testing of inhalable spray dried powders containing ciprofloxacin (CIP) and polymyxin B sulfate (PMB). CIP nanosuspensions with an average particle diameter of 435.9 ± 9.3 nm were initial...
Saved in:
Main Authors: | Zhengqi Xu (Author), Hriday Bera (Author), Hengzhuang Wang (Author), Junwei Wang (Author), Dongmei Cun (Author), Yu Feng (Author), Mingshi Yang (Author) |
---|---|
Format: | Book |
Published: |
Compuscript Ltd,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines
by: Yi Guo, et al.
Published: (2021) -
Drug Combination of Ciprofloxacin and Polymyxin B for the Treatment of Multidrug-Resistant <i>Acinetobacter baumannii</i> Infections: A Drug Pair Limiting the Development of Resistance
by: Junwei Wang, et al.
Published: (2023) -
In Vitro and In Vivo Evaluation of Inhalable Ciprofloxacin Sustained Release Formulations
by: Changzhi Shi, et al.
Published: (2023) -
The effect of ethanol on the habit and in vitro aerodynamic results of dry powder inhalation formulations containing ciprofloxacin hydrochloride
by: Edit Benke, et al.
Published: (2021) -
Mannose-Decorated Solid-Lipid Nanoparticles for Alveolar Macrophage Targeted Delivery of Rifampicin
by: Hriday Bera, et al.
Published: (2024)